SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-19-002302
Filing Date
2019-03-12
Accepted
2019-03-12 16:58:31
Documents
1
Period of Report
2019-03-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8716
  Complete submission text file 0000919574-19-002302.txt   11176
Mailing Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Reporting) CIK: 0001278386 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36646 | Film No.: 19675735

Mailing Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019
Business Address 724 FIFTH AVENUE 9TH FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD CAPITAL INC (Reporting) CIK: 0001278387 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36646 | Film No.: 19675734

Mailing Address
Business Address
BRADSHER NEAL C (Reporting) CIK: 0001278388 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36646 | Film No.: 19675733

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805
Asterias Biotherapeutics, Inc. (Issuer) CIK: 0001572552 (see all company filings)

IRS No.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)